Life Scientist > Biotechnology

Prima gets go ahead for ovarian cancer vaccine trial in US

02 September, 2009 by Tim Dean

FDA gives clearance for Phase IIb trial of CVac vaccine in the US.


Sirtex profits up eightfold

28 August, 2009 by Tim Dean

Gains made through increased sales and currency movements.


Australian biotech market watch 28/08/09

28 August, 2009 by Tim Dean

Sonic, Sirtex, Blackmores, Healthscope, Cellestis


A better test to detect DNA

28 August, 2009 by Staff Writers

Applications in diagnosing diease and investigating crimes.


Cellestis posts strong result

26 August, 2009 by Tim Dean

Financial year 2009 results are in showing record sales and profits.


New Sigma-Aldrich lab offers knockout rat models

24 August, 2009 by Staff Writers

CompoZr Zinc Finger Nuclease technology enables creation of next-generation rodent research models that can provide new insight into human disease.


CSL's ups and downs

20 August, 2009 by Tim Dean

CSL had it's share of ups and downs last year, but overall it's coming out on top.


LabTech awarded patent for key technology

18 August, 2009 by Tim Dean

Australian patent awarded for LabTech System's MicroStreak agar plate streaking technology.


CSIRO opens high tech green biolab

17 August, 2009 by Tim Dean

New environmentally-friendly biotechnology facility opened in Canberra.


Australian biotech market watch 13/08/09

13 August, 2009 by Tim Dean

BioPharmica, Ansell, Sonic, iSOFT, Progen, pSivida


UQ licenses hGH to PROLOR

12 August, 2009 by Staff Writers

IMBcom and PROLOR Biotech enter into technology licence for human growth hormone.


Prognosis good for Primary Health Care

12 August, 2009 by Tim Dean

Profits up more than tenfold following acquisition of Symbion in 2008.


BioProspect acquisition of Re-Gen complete

10 August, 2009 by Staff Writers

Plans to expand into rapidly growing Chinese market for natural health products.


Australian biotech market watch 07/08/09

07 August, 2009 by Tim Dean

ResMed, Ramsay, Biota, Sonic, Healthscope


Mesoblast targets heart failure in trial

05 August, 2009 by Tim Dean

Adult stem cells might eliminate the need for heart transplants in heart failure patients.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd